EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Non-coding RNAs regulation in breast cancer pathogenesis

Bala Gur Dedeoglu, Senem Noyan, Kübra Nur Kaplan İlhan

Epigenomics · 03.04.2026 · 18 (4) · 493-512

DOI: 10.1080/17501911.2026.2642583 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Epigenomics, online erschienen am 10.03.2026. Verfasst von Bala Gur Dedeoglu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnology Institute, Ankara University, Ankara, Türkiye. Hauptthemen laut MEDLINE: Breast Neoplasms, RNA, Untranslated, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer represents a molecularly heterogeneous disease shaped by complex genetic, epigenetic, and transcriptional dysregulation. Non-coding RNAs (ncRNAs) including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs) as well as small nucleolar RNAs (snoRNAs), piwi-interacting RNAs (piRNAs), and small nuclear RNAs (snRNAs), have emerged as key epigenetic regulators that integrate multiple layers of gene control. Through interactions with chromatin-modifying enzymes, RNA-binding proteins, and signaling effectors, ncRNAs modulate transcriptional activity, chromatin accessibility, and post-transcriptional stability of target genes. miRNAs predominantly act as post-transcriptional repressors, whereas lncRNAs and circRNAs exert transcriptional and epigenetic control via scaffolding, miRNA sponging, and chromatin remodeling; some circRNAs even encode functional peptides. Aberrant ncRNA expression contributes to proliferation, metastasis, metabolic reprogramming, immune evasion, and therapeutic resistance, with distinct expression signatures associated with triple-negative, HER2-positive, and hormone receptor - positive breast cancers. Owing to their stability and detectability in plasma and exosomes, ncRNAs hold promise as minimally invasive biomarkers for early detection and disease monitoring. Moreover, therapeutic strategies targeting ncRNAs, such as antisense oligonucleotides, RNA interference, CRISPR/Cas-based editing, and ncRNA-derived vaccines, are advancing toward clinical translation. Collectively, ncRNAs redefine the epigenetic landscape of breast cancer, offering a framework for integrated diagnostic and therapeutic approaches in precision oncology. Breast cancer is caused not only by changes in genes but also by small molecules called non-coding RNAs. These molecules help control how cells work and can affect tumor growth, spread of cancer, and response to treatment. Some of them can be found in blood samples, which means they could help detect breast cancer early, predict how it may develop, and guide doctors in choosing the best treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsRNA, UntranslatedGene Expression Regulation, NeoplasticHumansFemaleEpigenesis, GeneticPiwi-Interacting RNA

Stichwörter der Autor:innen

Breast cancerbiomarkersepigenetic regulationncRNA-targeted therapynon-coding RNAs (ncRNAs)

Substanzen

RNA, UntranslatedPiwi-Interacting RNA

Autor:innen und Institutionen

  • Biotechnology Institute, Ankara University, Ankara, Türkiye.

Zitieren

APA

Gur Dedeoglu, B., Noyan, S., & İlhan, K. N. K. (2026). Non-coding RNAs regulation in breast cancer pathogenesis. Epigenomics, 18(4), 493-512. https://doi.org/10.1080/17501911.2026.2642583

Vancouver

Gur Dedeoglu B, Noyan S, İlhan KNK. Non-coding RNAs regulation in breast cancer pathogenesis. Epigenomics. 2026;18(4):493-512. doi:10.1080/17501911.2026.2642583

BibTeX
@article{GurDedeoglu2026,
  author = {Gur Dedeoglu, Bala and Noyan, Senem and İlhan, Kübra Nur Kaplan},
  title = {Non-coding RNAs regulation in breast cancer pathogenesis},
  journal = {Epigenomics},
  year = {2026},
  volume = {18},
  number = {4},
  pages = {493--512},
  doi = {10.1080/17501911.2026.2642583}
}
Kostenlos starten →